Longer Time to Chemotherapy Linked to Worse Outcomes in Triple-Negative Disease

episode

Breastcancer.org Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 7PM EDT 4 min · 22 Sep 2026 · NPR News Now

Garry and Tim - Full Show - Wednesday September 23 (23.09.26) 1h 53m · 22 Sep 2026 · SEN Breakfast

H4 N2K, Shehan Jeyarajah, The Kicker 45 min · 22 Sep 2026 · The Program

US-Iran Talks on Sidelines of UN Summit, Chipmakers Rally, More 7 min · 22 Sep 2026 · Bloomberg News Now

7PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Dentists Are Making Millions From This Lie - Dr. Ellie Phillips EXPOSES the dental industry 1h 5m · 22 Sep 2026 · Redacted News

Report any issue

Source

Recorded17 Dec 2018

Publisherfeeds.megaphone.fm ↗

Handlerec:11088299

Show notes

Dr. Zaida Morante, medical oncologist at Instituto Nacional de Enfermedades Neoplásicas in Lima, Peru, explains her research that found delaying chemotherapy for more than 30 days was associated with worse outcomes in women diagnosed with early-stage, triple-negative breast cancer. Triple-negative breast cancer is breast cancer that is estrogen-receptor-negative, progesterone-receptor-negative, and HER2-negative. Listen to the podcast to hear Dr. Morante explain: the design of the study which outcomes delaying chemotherapy affected possible explanations for why chemotherapy was delayed for some women

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in